Back to search

United States· US:73927-0009_3341ef39-b2cf-a9a3-e063-6294a90ab223

Nobaton 1.5%Fine Salt ampoule

A medicinal product containing sodium monofluorophosphate; olaflur, registered in United States by BD TECHNOLOGY CO.,LTD.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedNobaton 1.5%Fine Salt ampouleATC—REGISTER NO.US:73927-0009_3341ef3…PACKS LISTED2CHECKEDJuly 26, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SODIUM MONOFLUOROPHOSPHATE; OLAFLUR
Manufacturer
BD TECHNOLOGY CO.,LTD
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
July 26, 2026

Packs & prices · 2

  • ndc11
    73927-0009-1
  • ndc11
    7392700091
    35 g in 1 TUBE (73927-0009-1)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fe1e410b-f0fe-4429-8d48-348f65d8adab
GET /v1/drugs/fe1e410b-f0fe-4429-8d48-348f65d8adab?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "DENTAL",
  "source": "ndc",
  "strength": ".0975; 1",
  "substance": "SODIUM MONOFLUOROPHOSPHATE; OLAFLUR",
  "productndc": "73927-0009",
  "dosage_form": "OINTMENT",
  "dea_schedule": null,
  "strength_unit": "g/100g; g/100g",
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG OTHER"
}

See everything about sodium monofluorophosphate; olaflur.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.